D
Emergent BioSolutions Inc. EBS
$5.71 $0.203.63%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue -0.54% 2.05% 2.79% 21.67% -6.10%
Total Other Revenue -- -- -- -- --
Total Revenue -0.54% 2.05% 2.79% 21.67% -6.10%
Cost of Revenue -3.05% -10.07% -5.26% -18.99% -16.78%
Gross Profit 4.24% 33.65% 27.37% 228.42% 24.34%
SG&A Expenses -16.26% -9.23% -8.71% -1.65% 5.07%
Depreciation & Amortization -0.76% -3.42% 0.00% 3.02% 9.52%
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -9.99% -0.82% 2.57% -4.29% -0.82%
Operating Income 69.18% 26.76% -1.10% 103.94% -53.16%
Income Before Tax 80.46% 76.99% -7.17% -48.62% -233.88%
Income Tax Expenses 62.80% -2.26% -85.71% -62.84% 495.95%
Earnings from Continuing Operations 74.94% 73.16% 2.44% -43.44% -259.40%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 74.94% 73.16% 2.44% -43.44% -259.40%
EBIT 69.18% 26.76% -1.10% 103.94% -53.16%
EBITDA 216.63% 337.80% -67.89% 199.84% -394.90%
EPS Basic 75.68% 73.83% 5.90% -39.99% -251.73%
Normalized Basic EPS 57.09% 30.72% -2.36% 73.42% -53.23%
EPS Diluted 74.97% 73.16% 5.95% -39.98% -251.48%
Normalized Diluted EPS 55.60% 28.86% -2.36% 73.42% -53.23%
Average Basic Shares Outstanding 3.67% 3.55% 3.89% 3.30% 2.04%
Average Diluted Shares Outstanding 4.89% 4.79% 3.89% 3.30% 2.04%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings